Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Bavarian Nordic A/S: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Mar 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Bavarian Nordic AS

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

19 Feb 2015 Wright Reports 56 $75.00

Bavarian Nordic A/S (BAVA) - Financial Analysis Review

Bavarian Nordic A/S (BAVA) - Financial Analysis Review Summary Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology compa...

03 Feb 2015 GlobalData 36 $125.00

Cell Therapy 2015: With Maturity Comes Promise

A number of new and innovative medical paradigms are being explored by companies in the life sciences sector, with one of the...

23 Dec 2014 Streetwise Reports 5 $35.00

Z:\Edison\Clients\Bavarian Nordic\published\2014\Dec 14 ADR Update

Bavarian Nordic’s $187m exclusive global licensing and supply deal for its development Ebola vaccine MVA-BN Filovirus with Ja...

04 Dec 2014 Edison Investment Research 7 $10.00

BAVARIAN NORDIC - STRATEGIC EBOLA DEAL FILLS 2015 REVENUE GAP

Bavarian Nordic’s $187m exclusive global licensing and supply deal for its development Ebola vaccine MVA-BN Filovirus with Ja...

04 Dec 2014 Edison Investment Research 7 $10.00

Company Snapshot - Bavarian Nordic A S

A director at Bavarian Nordic A S sold 5,615 shares at 186.541DKK and the significance rating of the trade was 61/100. Is th...

18 Nov 2014 Directors Deals Ltd. 1 $12.00

Bavarian Nordic A/S (BAVA) - Financial Analysis Review

Bavarian Nordic A/S (BAVA) - Financial Analysis Review Summary Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology compa...

03 Nov 2014 GlobalData 39 $125.00

BAVARIAN NORDIC - US IMVAMUNE CONTRACT CONFIRMED

Option exercise for the second portion of the Imvamune smallpox vaccine delivery contract to the US government unlocks valuat...

24 Sep 2014 Edison Investment Research 9 $10.00

BAVARIAN NORDIC - US IMVAMUNE CONTRACT CONFIRMED

Option exercise for the second portion of the Imvamune smallpox vaccine delivery contract to the US government unlocks valuat...

24 Sep 2014 Edison Investment Research 9 $10.00